应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ASPHF ASCENTAGE PHARMA GROUP
休市中 12-12 16:00:00 EST 延时
资讯
新帖
简况
亚盛医药再涨超7%近期配股净筹超14.9亿港元利沙托克拉新药上市申请获批
动脉网 · 07-17
亚盛医药再涨超7%近期配股净筹超14.9亿港元利沙托克拉新药上市申请获批
亚盛医药拟配股筹资最多15.4亿港元
DoNews · 07-14
亚盛医药拟配股筹资最多15.4亿港元
亚盛医药利刃出鞘
药智网 · 07-14
亚盛医药利刃出鞘
国产首个!亚盛医药Bcl-2抑制剂“利沙托克拉”获批上市
医药魔方Info · 07-10
国产首个!亚盛医药Bcl-2抑制剂“利沙托克拉”获批上市
公司概况
公司名称:
ASCENTAGE PHARMA GROUP
所属市场:
PINK LIMITED
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"ASPHF","market":"US","secType":"STK","nameCN":"ASCENTAGE PHARMA GROUP","latestPrice":8.48,"timestamp":1765573200000,"preClose":8.48,"halted":0,"volume":0,"delay":15,"floatShares":286331303,"shares":371853475,"eps":-0.183888,"marketStatus":"休市中","change":0,"latestTime":"12-12 16:00:00 EST 延时","open":8.48,"high":8.48,"low":8.48,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.183888,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"exchange":"PINK LIMITED","adjPreClose":8.48,"volumeRatio":0.04132231541561373},"requestUrl":"/m/hq/s/ASPHF/wiki","defaultTab":"wiki","newsList":[{"id":"2552725281","title":"亚盛医药再涨超7%近期配股净筹超14.9亿港元利沙托克拉新药上市申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2552725281","media":"动脉网","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552725281?lang=zh_cn&edition=full","pubTime":"2025-07-17 10:06","pubTimestamp":1752717960,"startTime":"0","endTime":"0","summary":"亚盛医药-B股价涨超7%,配股筹14.93亿港元,新药利沙托克拉上市填补国内空白,全球商业化潜力大,有望成第二款获批的BCL-2抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071710152197a92516&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071710152197a92516&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ASPHF","AAPG"],"gpt_icon":0},{"id":"2551188991","title":"亚盛医药拟配股筹资最多15.4亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551188991","media":"DoNews","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551188991?lang=zh_cn&edition=full","pubTime":"2025-07-14 19:13","pubTimestamp":1752491583,"startTime":"0","endTime":"0","summary":"2025年7月14日,交易文件显示,亚盛医药计划通过先旧后新方式配售股份,预计筹资至多15.4亿港元(约1.96亿美元)。公司拟配售2,200万股股份,每股配售价在68.35至70港元之间,较上周一收盘价74.70港元折让6.3%-8.5%。此次配股旨在增强公司资金流动性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714191420954206e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714191420954206e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","06855","BK4139","ASPHF"],"gpt_icon":0},{"id":"2551927949","title":"亚盛医药利刃出鞘","url":"https://stock-news.laohu8.com/highlight/detail?id=2551927949","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551927949?lang=zh_cn&edition=full","pubTime":"2025-07-14 09:43","pubTimestamp":1752457417,"startTime":"0","endTime":"0","summary":"近日,根据NMPA官网的消息,亚盛医药万众期待的管线利沙托克拉片已附条件批准上市,用于既往经过至少包含布鲁顿酪氨酸激酶抑制剂在内的一种系统治疗的成人慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者。利刃出鞘维奈克拉上市之后,近十年之久无后来者,而直到如今,第二款药物——利沙托克拉片才获批上市。亚盛医药的后备军作为一家目前市值已经较高的biotech,亚盛医药肯定不止奥雷巴替尼和APG-2575两个大单品支撑,后面肯定还有生力军。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714094538a6a78424&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714094538a6a78424&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","AAPG","ASPHF","BK1161","BK1574"],"gpt_icon":0},{"id":"2550314611","title":"国产首个!亚盛医药Bcl-2抑制剂“利沙托克拉”获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2550314611","media":"医药魔方Info","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550314611?lang=zh_cn&edition=full","pubTime":"2025-07-10 15:43","pubTimestamp":1752133404,"startTime":"0","endTime":"0","summary":"APG-2575是亚盛医药自主研发的新型口服Bcl-2选择性抑制剂,通过选择性抑制Bcl-2蛋白,恢复癌细胞的正常凋亡过程,从而达到治疗肿瘤的目的。Bcl-2抑制剂的出现让CLL/SLL的治疗有了进一步的革新。不过Bcl-2靶点成药性难度很高,靶点发现至今近40年,全球只有一款靶向Bcl-2的抑制剂获批上市,即艾伯维维奈克拉,此外,百济神州的索托克拉已申请上市,目前正在审评当中。力胜克拉的获批将为患者提供新的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710155605a44207f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710155605a44207f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","ASPHF","AAPG","06855","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascentagepharma.com","exchange":"PINK LIMITED","name":"ASCENTAGE PHARMA GROUP","nameEN":"ASCENTAGE PHARMA GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ASCENTAGE PHARMA GROUP(ASPHF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ASCENTAGE PHARMA GROUP(ASPHF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ASCENTAGE PHARMA GROUP,ASPHF,ASCENTAGE PHARMA GROUP股票,ASCENTAGE PHARMA GROUP股票老虎,ASCENTAGE PHARMA GROUP股票老虎国际,ASCENTAGE PHARMA GROUP行情,ASCENTAGE PHARMA GROUP股票行情,ASCENTAGE PHARMA GROUP股价,ASCENTAGE PHARMA GROUP股市,ASCENTAGE PHARMA GROUP股票价格,ASCENTAGE PHARMA GROUP股票交易,ASCENTAGE PHARMA GROUP股票购买,ASCENTAGE PHARMA GROUP股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ASCENTAGE PHARMA GROUP(ASPHF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ASCENTAGE PHARMA GROUP(ASPHF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}